Special Alerts:
[Posted 01/24/2008; Selected revisions 6/25/08] Bayer and FDA informed healthcare professionals of the market withdrawal of the current liquid formulation of sargramostim (Leukine), a growth factor that helps fight infection and disease in appropriate patients by enhancing immune cell function. The product was withdrawn because of an upward trend in spontaneous reports of adverse reactions, including syncope (fainting), which are temporally correlated with a change in the formulation of liquid Leukine to include edetate disodium (EDTA). The upward trend in adverse reaction reporting rates has not been observed with the use of lyophilized Leukine.
Bayer has since reformulated liquid Leukine and this EDTA-free Leukine preparation is now available through normal distribution channels. Healthcare professionals should immediately stop using liquid Leukine preparations containing EDTA and return unused vials to the manufacturer. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#Leukine and http://www.fda.gov/medwatch/safety/2008/Leukine_DHCP_01-23-2008.pdf and the manufacturer’s website at: http://www.leukine.com.
|
|
Search by color, shape and markings. click here
|
|
Check any 2 drugs for interactions. click here
|
|
|
Compare any two drugs side by side. click here
|
|
|
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
|
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.